The expectorant therapy for acute respiratory infections in children
Keywords:expectorant therapy, acute respiratory infections, preparation of dried ivy leaf extract, Pectolvan Ivy, children, review
AbstractThis literature review provides current information on the use of expectorant therapy for acute respiratory infections in children. For writing the article, we used such databases, as Scopus, Web of Science, MedLine, PubMed, Google Scholar, CyberLeninka, Russian Science Citation Index. Attention is focused of the choice of pathogenetic therapy for cough in a child with regard to the efficiency and safety of the drug. Based on the information search, we have systematized the data on the pharmacological properties and evidence of clinical efficacy, tolerability and safety of using an effective herbal expectorant drug with reflex action, namely, Pectolvan Ivy (Pectolvan hedera helix), preparation of dried ivy leaf extract, in the treatment of acute respiratory infections in children.
Abaturov OYe, Agafonova YeA, Tokarevа NM, Babych VL. Bacterial lysates as a key drug component of the prevention and treatment for acute respiratory infections in children. Zdorovʹe rebenka. 2015;(65):95-101. doi: 10.22141/2224-05188.8.131.525.74909. (in Russian).
Abaturov OYe, Gerasimenko ON, Vysochina IL, Zavgorodniaia NIu. Defenziny i defenzin-zavisimye zabolevaniia [Defensins and defensin-dependent diseases]. Оdessa: Izdatel'stvo VMV; 2011. 265 p. (in Russian).
Antypkin JG, Chumachenko NG, Lapshin VF, Umanets TR. The aspects of respiratory organs pathological conditions dynamics among child population. Sovremennaya Pediatriya. 2016;(74):73-77. (in Ukrainian).
Tumanov VA, Pokanevich VV, Garnik TP, Frolov VM, Peresadin NA. Phytotherapy: application modern lines in medical practice and perspectives of the further development. Phitoterapiya. 2012;(1):4-11. (in Ukrainian).
Lysenko JuV. Efficiency of domestic herbal medicine Pectolvan Ivy in patients with acute inflammatory diseases of the respiratory tract. In: Demihova NV, editor. Collection of abstracts of the III International Scientific and Practical Conference of Students and Young Scientists on Actual Problems in Theoretical and Practical Medicine. 2015 Apr 23-24; Sumy, Ukraine. Sumy; 2015. 62-63 pp. (in Ukrainian).
Marushko YuV, Hracheva MG. Therapy in bronchopulmonary diseases associated with increased secretion of viscous sputum and impaired mucus transport. Zdorovʹe rebenka. 2015;1(60):135-139. doi: 10.22141/2224-05184.108.40.2065.74978. (in Ukrainian).
Marushko YuV, Moskovenko OD. Dry cough in children: сauses, peculiarities of respiratory diseases and treatment. Zdorovʹe rebenka. 2015;(60):109-114. doi: 10.22141/2224-05220.127.116.115.74973 (in Ukrainian).
Marushko YuV, Moskovenko OD. Experience with Ivy Leaf Extract in the Treatment of Acute Obstructive Bronchitis in Children. Zdorovʹe rebenka. 2016;(73):45-49. doi: 10.22141/2224-0518.104.22.1686.78298. (in Ukrainian).
Ohotnikova OM, Rudenko SM, Gladush JuI, et al. Possibilities of the use of phytotherapy in children over five years of life with obstructive bronchitis and bronchial asthma. Zdorov’ja Ukrai'ny. Pediatrija. 2012;(22):38-39. (in Ukrainian).
Soroka ND, Korshunova EV, Riabykh OV, Balatskaia GM, Kuznetsova NV, Belan EIu. Efficiency and safety of inhalation method of treatment with dry extract of ivy leaves of acute respiratory diseases in infants. Lechaschii Vrach. 2010;(6):38. (in Russian).
Shafranskij VV; Ministry of Health of Ukraine, Ukrainian Institute of Strategic Researches of the Ministry of Health of Ukraine, editors. Shhorichna dopovid' pro stan zdorov’ja naselennja, sanitarno-epidemichnu sytuaciju ta rezul'taty dijal'nosti systemy ohorony zdorov’ja Ukrai'ny. 2015 rik [Annual report on the health status of the population, the sanitary and epidemiological situation and the results of the health care system of Ukraine 2015]. Kyiv: Medinform; 2016. 452 p. (in Ukrainian).
Yulish YeI. Pathogenetic reasoning of administration of mucolytic agents for respiratory diseases in children. Zdorovʹe rebenka. 2015;(60):89-92. doi: 10.22141/2224-0522.214.171.1245.74964. (in Russian).
Bolbot Y, Prokhorov E, Mokia S, Yurtseva A. Comparing the efficacy and safety of high-concentrate (5-7.5:1) ivy leaves extract and acetylcysteine for treatment of children with acute bronchitis. Liky Ukrai'ny. 2004;(11):1-4.
Büechi S, Kahler D. Ivy (hedera helix) for respiratory diseases. An open clinical study with ivy pastilles. Schweiz Zschr Ganzheitsmedizin. 2003;(15):124-128. (in German).
Büechi S, Vögelin R, von Eiff MM, Ramos M, Melzer J. Open trial to assess aspects of safety and efficacy of a combined herbal cough syrup with ivy and thyme. Forsch Komplementarmed Klass Naturheilkd. 2005 Dec;12(6):328-32.
Fazio S, Pouso J, Dolinsky D, et al. Tolerance, safety and efficacy of Hedera helix extract in inflammatory bronchial diseases under clinical practice conditions: a prospective, open, multicentre postmarketing study in 9657 patients. Phytomedicine. 2009 Jan;16(1):17-24. Epub 2006 Jul 24. doi:10.1016/j.phymed.2006.05.003.
Hofmann D, Hecker M, and Völp A. Efficacy of dry extract of ivy leaves in children with bronchial asthma - a review of randomized controlled trials. Phytomedicine. 2003 Mar;10(2-3):213-20. doi: 10.1078/094471103321659979.
Holzinger F, Chenot JF. Systematic review of clinical trials assessing the effectiveness of ivy leaf (hedera helix) for acute upper respiratory tract infections. Evid Based Complement Alternat Med. 2011;2011:382789. doi: 10.1155/2011/382789.
Kemmerich B, Eberhardt R, Stammer H. Efficacy and tolerability of a fluid extract combination of thyme herb and ivy leaves and matched placebo in adults suffering from acute bronchitis with productive cough: a prospective, double-blind, placebo-controlled clinical trial. Arzneimittelforschung. 2006;56(9):652-60. doi: 10.1055/s-0031-1296767.
Marzian O. Treatment of acute bronchitis in children and adolescents. Non-interventional postmarketing surveillance study confirms the benefit and safety of a syrup made of extracts from thyme and ivy leaves. MMW Fortschr Med. 2007 Jun 28;149(27-28 Suppl):69-74. (in German).
Meepagala KM, Briscoe WE, Techen N, Johnson RD, Clausen BM, Duke SO. Isolation of a phytotoxic isocoumarin from Diaporthe eres-infected Hedera helix (English ivy) and synthesis of its phytotoxic analogs. Pest Manag Sci. 2018 Jan;74(1):37-45. doi: 10.1002/ps.4712.
Rehman SU, Kim IS, Choi MS, Kim SH, Zhang Y, Yoo HH. Time-dependent Inhibition of CYP2C8 and CYP2C19 by Hedera helix Extracts, A Traditional Respiratory Herbal Medicine. Molecules. 2017 Jul 24;22(7). pii: E1241. doi: 10.3390/molecules22071241.
Roşca-Casian O, Mircea C, Vlase L, Gheldiu AM, Teuca DT, Pârvu M. Chemical composition and antifungal activity of Hedera helix leaf ethanolic extract. Acta Biol Hung. 2017 Jun;68(2):196-207. doi: 10.1556/018.68.2017.2.7.
Schaefer A, Kehr MS, Giannetti BM, Bulitta M, Staiger C. A randomized, controlled, double-blind, multi-center trial to evaluate the efficacy and safety of a liquid containing ivy leaves dry extract (EA 575®) vs. placebo in the treatment of adults with acute cough. Pharmazie. 2016 Sep 1;71(9):504-509. doi: 10.1691/ph.2016.6712.
Smith-Hall C, Larsen HO, Pouliot M. People, plants and health: a conceptual framework for assessing changes in medicinal plant consumption. J Ethnobiol Ethnomed. 2012 Nov 13;8:43. doi: 10.1186/1746-4269-8-43.
Song KJ, Shin YJ, Lee KR, Lee EJ, Suh YS, Kim KS. Expectorant and antitussive effect of Hedera helix and Rhizoma coptidis extracts mixture. Yonsei Med J. 2015 May;56(3):819-24. doi: 10.3349/ymj.2015.56.3.819.
Sun D, Shen W, Zhang F, et al. α-Hederin inhibits interleukin 6-induced epithelial-to-mesenchymal transition associated with disruption of JAK2/STAT3 signaling in colon cancer cells. Biomed Pharmacother. 2018 May;101:107-114. doi: 10.1016/j.biopha.2018.02.062.
How to Cite
Copyright (c) 2018 A.E. Abaturov, V.L. Babich, N.M. Tokareva
This work is licensed under a Creative Commons Attribution 4.0 International License.